Sector Experts

Ross Silver

Vista Partners

Image: Ross Silver

Ross Silver has been advising, researching and investing in public companies across all industries throughout his career. Prior to founding Vista Partners LLC in 2005, Silver served as a research analyst for a San Francisco-based hedge fund. From 2000 to 2003, Silver served as a research associate covering consumer discretionary and consumer staple companies at Dresdner RCM (now Allianz). Prior to joining Dresdner RCM, Silver was a member of CIBC's Technology, Media, and Telecom Investment Banking group, where he assisted with equity and debt offerings. Silver holds a bachelor's degree in business economics from the University of California, Santa Barbara. He has served as a consultant for government agencies including the National Institutes of Health (NIH). He holds a Series 65 Securities license.




Recent Interviews

Ross Silver on How to Find the Perfect Combo of Biotech Science and Market Savvy (12/6/12) Many components go into building a successful biotech company, but excellent management is a keystone. Combine good management with an innovative product or service, and investors can possibly unlock big multiples over their original investments. So says Principal Analyst and Fund Manager Ross Silver, co-founder of Vista Partners. In this interview with The Life Sciences Report, Silver brings obscure micro-cap ideas to life and discusses why they may have mammoth potential.

Recent Quotes

"We initiate coverage on URZ; its offtake agreements are for prices 50% higher than the current price of uranium." (3/26/14) Uranerz Energy Corp. - Ross Silver, Vista Partners More >

"We are initiating coverage on SNGX; we estimate its NPV to be $138M." (3/18/14) Soligenix Inc. - Ross Silver, Vista Partners More >

"ACFN has an experienced management team with proven ability to monetize subsidiaries." (3/28/13) Acorn Energy Inc. - Ross Silver, Vista Partners More >

"OCLS grew product revenue by 32% YOY." (1/3/13) Oculus Innovative Sciences Inc. - Ross Silver, Vista Partners More >

"ACFN is a very compelling investment opportunity." (1/3/13) Acorn Energy Inc. - Ross Silver, Vista Partners More >

"ACFN's four portfolio companies are each positioned in multibillion-dollar markets." (12/6/12) Acorn Energy Inc. - The Life Sciences Report interview with Ross Silver More >

"OCLS has an alternative to antibiotics, and it won't cause resistant bacteria to evolve. That's what's so exciting." (12/6/12) Oculus Innovative Sciences Inc. - The Life Sciences Report Interview with Ross Silver More >

"ACFN is a very compelling investment opportunity." (7/2/12) Acorn Energy Inc. - Ross Silver, Vista Partners More >



Due to permission requirements, not all quotes are shown.